Cancer Advocates Sought Increased Federal Research Funding

More than 750 advocates traveled to Capitol Hill to push for budget boosts aimed at improving national clinical trial access.

Updated on Sept. 29, 2026 in Cancer

Isometric editorial illustration of a laboratory centrifuge on a workbench, symbolizing clinical research and federal health funding efforts. — Cancer advocates met with lawmakers in late September to secure $51.3 billion in federal funding for the National Institutes of Health. AI Illustration. Upload story photo >

Live Poll

Should the federal government increase its annual spending on cancer research and prevention?

Over 750 cancer patients and advocates met with lawmakers on September 29, 2026, to request $51.3 billion for the National Institutes of Health. This advocacy effort seeks to address the significant disease burden in states like South Carolina, where nearly 37,000 new cases are diagnosed annually.

Why it matters

Advocates are targeting federal budget allocations to lower financial barriers and expand access to clinical trials for patients across the country. These efforts aim to enhance early detection and prevention services for those navigating complex cancer treatment paths.

Advocates presented data highlighting an annual toll of 37,000 new diagnoses and 12,000 deaths from cancer in South Carolina alone. These figures ground the request for federal resources, though the specific impact of these potential funding levels on individual survival outcomes remains unknown.

The players

American Cancer Society Cancer Action Network

The advocacy affiliate of the American Cancer Society that focuses on promoting evidence-based public health policies and research funding.

National Institutes of Health

The primary federal agency responsible for biomedical and public health research, which supports institutions working on cancer therapies.

The details

The advocacy push centers on the Clinical Trial Modernization Act, which aims to remove systemic hurdles that prevent many patients from participating in experimental therapies. By increasing funding for the National Institutes of Health, supporters hope to accelerate the pipeline for new treatments while bolstering specialized screening programs for breast and cervical cancers.

September 29, 2026: Advocates held direct meetings with representatives on Capitol Hill.

Health Landscape

This advocacy effort builds upon the objectives of the Clinical Trial Modernization Act to reduce barriers to research participation. It represents a pivot toward addressing the systemic financial and logistical obstacles that current standard-of-care models often fail to mitigate.

For those managing a diagnosis, these funding requests underscore the importance of discussing clinical trial options with your oncology team to see if you are a candidate for emerging treatments. Monitoring local health department updates on screening programs can also ensure you access available preventive care.

The takeaway

Advocacy for federal funding directly impacts the accessibility of clinical trials and preventive screenings. Patients and caregivers are encouraged to consult with their physicians about current trial eligibility and local resources for early cancer detection.